Key terms

About SIBN

SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in Santa Clara, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest SIBN news

Apr 17 4:02am ET Truist Financial Sticks to Their Buy Rating for SI-Bone (SIBN) by TipRanks Apr 03 11:25am ET SI-Bone’s Favorable Outlook and Buy Rating Amidst Stable Medical Coverage and Growth Prospects by TipRanks Mar 28 6:40am ET SI-Bone initiated with an Overweight at Piper Sandler by TipRanks Mar 13 7:54am ET Jefferies would be buyers of SI-Bone at current levels by TipRanks Mar 13 6:38am ET Buy Rating Affirmed for SI-Bone on Expansion and Market Growth Strategies by TipRanks Feb 27 8:58am ET SI-Bone price target lowered to $24 from $26 at Truist by TipRanks Feb 27 8:36am ET SI-Bone (SIBN) Gets a Buy from Cantor Fitzgerald by TipRanks Feb 27 7:43am ET Truist Financial Sticks to Its Buy Rating for SI-Bone (SIBN) by TipRanks Feb 27 7:21am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: CSL (OtherCMXHF), Aurora Cannabis (ACB) and SI-Bone (SIBN) by TipRanks Feb 27 5:49am ET SI-Bone’s Strong Growth and Optimistic Profitability Outlook Justify Buy Rating by TipRanks Feb 27 12:37am ET SI-Bone’s Strong Outperformance and Promising Outlook Secure Buy Rating by TipRanks Feb 26 4:32pm ET SI-Bone sees FY24 revenue $162M-165M, consensus $159.06M by TipRanks Feb 26 4:31pm ET SI-Bone reports Q4 EPS (27c), consensus (28c) by TipRanks Jan 30 8:35am ET SI-Bone receives FDA 510k clearance for smaller diameter of iFuse Implant by TipRanks Jan 22 7:05am ET SI-Bone price target raised to $25 from $24 at Canaccord by TipRanks

No recent press releases are available for SIBN

SIBN Financials

1-year income & revenue

Key terms

SIBN Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

SIBN Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

People walk past the New York Stock Exchange Thursday, March. 21, 2024.
Yuki Iwamura/AP
Investors are fearful. They shouldn’t be
People walk past the New York Stock Exchange (NYSE) on March 28, 2024 in New York City.
NDZ/STAR MAX/IPx/AP
What stalled this year’s seemingly infallible stock market rally
A working oil pumpjack is pictured in Taft, Kern County, California on September 21, 2023.
Frederic J. Brown/AFP/Getty Images
Oil prices get short-lived boost from attack on Iran
NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue